|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02393 YESTAR HEALTH
Nominal 
0.072 -0.004 (-5.263%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 1,273,785 | -46.095% | 2,363,002 | 1,966,063 | 2,322,702 | 1,602,278 |
| Cost of Sales | (1,056,145) | -43.179% | (1,858,736) | (1,671,899) | (1,875,636) | (1,314,593) |
| Gross Profit | 217,640 | -56.840% | 504,266 | 294,164 | 447,066 | 287,685 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 12,394 | 36.694% | 9,067 | (6,741) | (6,542) | (7,511) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 4,830 | 7,891 | 5,894 | 0 | |
| Profit / (Loss) before Taxation | 1,112,323 | 1772.282% | 59,410 | (208,248) | 153,724 | (767,446) | |
| Taxation | (19,798) | -58.574% | (47,791) | 24,192 | (32,847) | 64,599 | |
| Profit / (Loss) from Discontinued Operations | 536 | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,822) | -52.237% | (8,002) | 18,772 | (8,972) | 62,594 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,089,239 | 30014.432% | 3,617 | (165,284) | 111,905 | (640,253) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 21,240 | -81.966% | 117,775 | 103,054 | 59,045 | 58,585 |
| Depreciation & Amortisation | 42,101 | -50.107% | 84,382 | 122,652 | 112,091 | 133,205 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 47.000 | 29275.000% | 0.160 | -7.090 | 4.750 | -27.050 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.265 | -- | (0.199) | 0.218 | 0.369 | 0.250 |
| Remarks: | Real time quote last updated: 06/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,089,239 |
| %Change | 30014.432% |
| EPS / (LPS) | RMB 0.470 |
| NBV Per Share (¥) | RMB 0.265 |